GSK

Showing 15 posts of 760 posts found.

GSK image

GSK to cull Australian tablet packaging plant

May 23, 2013
Manufacturing and Production Australia, GSK

A GlaxoSmithKline tablet packaging facility in Australia will be closed with the loss of 120 jobs, around a third of …

GSK gets $200m from White House

May 23, 2013
Research and Development, Sales and Marketing AMR, BARDA, GSK, HHS, white house

GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow …

Funding boost for GSK open lab

May 7, 2013
Research and Development, Sales and Marketing GSK, Wellcome

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …

FDA image

FDA seeks manufacturing data for GSK’s trametinib

May 2, 2013
Manufacturing and Production FDA, GSK, melanoma

GlaxoSmithKline’s melanoma drug candidate trametinib has been delayed in the US by an FDA request for more information on its …

GSK abandons Parkinson’s drug

May 1, 2013
Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …

GSK image

GSK submits UMEC monotherapy

April 29, 2013
Sales and Marketing COPD, EMA, GSK, UMEC

GlaxoSmithKline has put its investigational once-daily medicine umeclidinium bromide (UMEC) up for scrutiny by European regulators for patients with chronic …

GSK image

GSK faces £2.6 billion fine

April 19, 2013
Sales and Marketing GSK, Seroxat, paroxetine

GlaxoSmithKline could be fined £2.6 billion after the Office of Fair Trading (OFT) alleged it paid generics firms to slow …

GSK image

FDA delays GSK flu vaccine

March 27, 2013
Research and Development, Sales and Marketing FDA, GSK, Vaccine

The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …

Witty image

GSK’s Witty: ‘Drugs should be cheaper’

March 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty

Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …

Hospira image

Hospira woes continue as GSK sues over quality failures

March 5, 2013
Manufacturing and Production GSK, Hospira

The difficulties besetting generic firm and contract manufacturer Hospira have taken a new turn with the news that one of …

GSK image

Abbott, GSK cut staff at Irish facilities

February 26, 2013
Manufacturing and Production Abbottt, GSK, Ireland

GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …

GSK image

FDA accepts GSK’s Anoro

February 20, 2013
Research and Development, Sales and Marketing FDA, GSK, Theravance, anoro

The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …

GSK image

GSK plans greater use of biocatalysis, continuous processing

February 19, 2013
Manufacturing and Production GSK, Witty, biocatalysis

GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …

ViiV HIV drug boost

February 18, 2013
Sales and Marketing Dolutegravir, GSK, HIV, ViiV

ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …

GSK image

‘Challenging’ Europe slows GSK

February 8, 2013
Sales and Marketing GSK, austerity, restructuring

‘Challenging’ economic conditions in Europe are among the factors GlaxoSmithKline is blaming for its sluggish performance, with turnover worldwide down …

The Gateway to Local Adoption Series

Latest content